CD34 and myelodysplastic syndrome: In contrast to the majority of the abovementioned studies that used cancer cells lines or murine models, we investigated the effect of AZA on the pattern of ERE expression on CD34+ primary hematopoietic stem cells (HSCs) derived from patients with MDS undergoing treatment with AZA (86).